Yulin Ren Selected Research

Yulin Ren Research Topics

Disease

30	Neoplasms (Cancer) 05/2023 - 08/2012
9	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023 - 10/2021
4	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2017
4	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2023 - 08/2012
2	Heart Failure 06/2021 - 01/2020
2	Neurofibrosarcoma (MPNST) 01/2020 - 01/2016
2	Meningioma (Meningiomas) 01/2018 - 10/2013
2	Neurilemmoma (Schwannoma) 01/2016 - 10/2013
2	Hyperglycemia 01/2013 - 05/2006
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	COVID-19 11/2022
1	Blister (Bulla) 01/2021
1	Heart Diseases (Heart Disease) 05/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Calcinosis 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Leukemia 01/2018
1	Cough 01/2018

Drug/Important Bio-Agent (IBA)

6	LactonesIBA 12/2020 - 03/2012
5	Cardiac GlycosidesIBA 01/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2013
4	Adenosine Triphosphatases (ATPase)IBA 01/2023 - 01/2020
4	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2013
3	Digoxin (Digitek)FDA LinkGeneric 01/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2020
3	Eukaryotic Initiation Factor-4F (EIF4F)IBA 01/2020 - 01/2016
3	silvestrolIBA 01/2020 - 01/2016
2	pembrolizumabIBA 05/2023 - 01/2022
2	5,3'- dihydroxy- 3,6,7,8,4'- pentamethoxyflavoneIBA 10/2022 - 03/2021
2	TriterpenesIBA 12/2021 - 08/2019
2	Insulin (Novolin)FDA Link 01/2020 - 01/2013
2	diphyllinIBA 01/2018 - 06/2014
2	LignansIBA 01/2018 - 06/2014
2	Caspase 3 (Caspase-3)IBA 01/2018 - 06/2014
2	Eukaryotic Initiation Factor-4EIBA 01/2018 - 01/2016
2	strebloside-IBA 01/2017 - 01/2017
2	SesquiterpenesIBA 01/2016 - 03/2012
2	Prostaglandins GIBA 07/2014 - 10/2005
2	furanoheliangolideIBA 10/2013 - 01/2013
1	RNA (Ribonucleic Acid)IBA 05/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	Taxoids (Taxanes)IBA 01/2023
1	taxaneIBA 01/2023
1	Indole AlkaloidsIBA 01/2023
1	vinflunineIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023
1	Vindesine (Vindesin)IBA 01/2023
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	VincamineIBA 01/2023
1	AcetylcholinesteraseIBA 01/2023
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2023
1	AlkaloidsIBA 01/2023
1	AntioxidantsIBA 01/2023
1	CamptothecinIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Epoxy Compounds (Epoxides)IBA 01/2023
1	QuercetinIBA 11/2022
1	Chlorogenic AcidIBA 11/2022
1	Protein Isoforms (Isoforms)IBA 10/2022
1	FlavonoidsIBA 10/2022
1	2H- 8- (2- senecioyloxy- 3- methylbut- 2- enoyl)- 7- methoxy- 1- benzopyran- 2- oneIBA 10/2022
1	interleukin-21 (interleukin 21)IBA 01/2022
1	lupeolIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	dipyrithioneIBA 12/2021
1	pyracrenic acidIBA 12/2021
1	AcidsIBA 12/2021
1	nyasolIBA 12/2021
1	Betulinic AcidIBA 12/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	DigoxigeninIBA 06/2021
1	flavoneIBA 03/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Cantharidin (Cantharides)IBA 01/2021
1	Monoterpenes (Monoterpenoids)IBA 01/2021
1	EndostatinsIBA 01/2021
1	palasoninIBA 01/2021
1	AnhydridesIBA 01/2021
1	Terpenes (Terpenoids)IBA 12/2020
1	betulinIBA 12/2020
1	rocaglamideIBA 01/2020
1	CaspasesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CardenolidesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Chloroform (Trichloromethane)IBA 01/2018

Therapy/Procedure

7	Therapeutics 05/2023 - 10/2005
3	Drug Therapy (Chemotherapy) 05/2023 - 01/2022
2	Immunotherapy 05/2023 - 01/2023
1	Neoadjuvant Therapy 05/2023
1	Intravenous Injections 01/2021